Using Predictive Intelligence to Uncover the Rare Disease Patient Journey

Dive Brief: In a deeper move into radiopharmaceuticals, Roche’s Genentech unit will collaborate with the Japan-based biotechnology company PeptiDream to develop “peptide-radioisotope” conjugates, PeptiDream said Wednesday. PeptiDream will use its peptide discovery platform system to identify and develop candidates for potential cancer drugs against targets Genentech will focus on. Under the deal,